ICON to Create Translational Medicine Unit in UK

Monday, December 21, 2009 07:53 AM

Dublin-based contract research organization (CRO) ICON is preparing to open a new hospital-based translational medicine unit in the UK—the result of a partnership with the Central Manchester University Hospitals Foundation (CMFT).

Under the terms of the agreement, signed last summer, ICON will create translational medicine facilities on the newly developed Manchester Royal Infirmary (MRI) campus. The exclusive agreement, which runs until 2012, will help ICON meet increasing demand for hospital-based first-in-human studies.

The new unit—the first deliverable from the ICON-CMFT collaboration—will open in April, and will include 34 beds, an onsite Good Manufacturing Practices pharmacy, a sample handling laboratory and administrative space. It will be connected to MRI’s Accident and Emergency Department.  The unit will also offer environmentally controlled pharmacodynamic study testing suites.

ICON will develop an additional facility on the MRI campus.

The CRO would not comment on the size of its translational medicine business but said translational research is a growth area.

 

Share:          
CWWeekly

June 29

FDA and PatientsLikeMe collaborate to test social media adverse event reporting

Boston-area teaching hospitals launch web portal to attract life science companies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

Integrated research partnerships build momentum
Research function provides infrastructure, leverages large pool of health systems' patients and data

'Right to Try' laws challenge clinical trial process
20 states pass, 20 more pending allowing access to study drugs without FDA and IRB approval

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

TransCelerate Biopharma turns three
High-profile consortium has made inroads fixing wasteful practices, but it still has more work ahead

Pharma industry improves its tarnished reputation
Delivering innovation, social responsibility will help rebuild trust

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs